1 / 8

Gingivitis-Global API Manufacturers, Marketed and Phase III

The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape.

bharatbookseo
Télécharger la présentation

Gingivitis-Global API Manufacturers, Marketed and Phase III

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  2. Summary Gingivitis-API Insights, 2015,report provides Gingivitis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Gingivitis. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape.The research analysis also presents the global sales forecasts data for the Gingivitis drugs till 2016.The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. W : www.bharatbook.com , T :  +91 22 27810772, 27810773, E :  info@bharatbook.com

  3. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China. W : www.bharatbook.com , T :  +91 22 27810772, 27810773, E :  info@bharatbook.com

  4. Data SourcesThe report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. W : www.bharatbook.com , T :  +91 22 27810772, 27810773, E :  info@bharatbook.com

  5. Scope• A snapshot of the global Market therapeutics scenario for Gingivitis.• A review of the marketed products under prescription for Gingivitis, regulatory information and marketing status.• Coverage of global patent coverage and detailed commentaries on the US patent challenges. • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.• Product profiles for marketed products for Gingivitis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.• Coverage of API Manufacturers for Gingivitis drugs in the United States, Europe and Asian Regions with location details.• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Gingivitis drugs.• Key discontinued Marketed products.• Global Sales Figure from 2012-2016. W : www.bharatbook.com , T :  +91 22 27810772, 27810773, E :  info@bharatbook.com

  6. Reasons to Buy• Evaluate the marketing status and exclusivity details of Gingivitis key products to exploit opportunities for generic drug development opportunities.• Key players in the pharmaceutical industry.•Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Gingivitis.• API intelligence over marketed drugs for Gingivitis and gaining primary intelligence over active ingredients manufacturers across the globe.• Uncovering opportunities in the rapidly growing the US markets. W : www.bharatbook.com , T :  +91 22 27810772, 27810773, E :  info@bharatbook.com

  7. Table of Contents Indication Overview Marketed Drugs Assessment Marketed Details of Drugs by Application Type Marketed Details of Drugs (NDA) by Marketing Status Marketed Details of Drugs by Patent Expiration Timeline The Active Pharmaceutical Ingredient (API) Manufacturers Assessment The API Manufacturers by the United States Drug Master File (US DMF) Status. The API Manufacturers by the US DMF Status (Drug Specific) Drugs Market Data and Forecasted Sales Figures (2012-2016) W : www.bharatbook.com , T :  +91 22 27810772, 27810773, E :  info@bharatbook.com

  8. To view the full Executive Summary and Table of Contents, please visit: Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Contact Us:-Call India: +91-22-27810772/73Email id : info@bharatbook.comWebsite : www.bharatbook.comOur Blog : https://www.bharatbook.com/blog/ Follow Us On :

More Related